18F-FDG PET心肌存活评估:一种实用省时方案
该研究评估了缺血性心肌病(ICM)患者(含或不含2型糖尿病)在静脉葡萄糖负荷和胰岛素注射后行18F-FDG PET心肌存活评估的图像质量,并与口服葡萄糖负荷方案比较代谢准备时间(MPP)。结果显示静脉方案MPP显著缩短,95%患者图像质量达良好至优秀,但非糖尿病患者图像质量优于糖尿病患者。
要点
- 静脉葡萄糖负荷联合胰岛素方案使MPP较口服方案缩短61%。
- 95%的ICM患者获得良好至优秀的图像质量。
- 非糖尿病患者的图像质量评分显著优于糖尿病患者。
核心结论
- 静脉葡萄糖负荷和胰岛素给药方案将MPP较口服葡萄糖负荷缩短61%,并使95%的ICM患者获得良好至优秀的图像质量。
研究设计与样本
- 前瞻性研究纳入59例连续ICM患者(年龄63±10岁;48男11女),行静息99mTc-tetrofosmin SPECT/CT和18F-FDG PET/CT评估心肌存活。
- 另以15例接受口服葡萄糖负荷和静脉胰岛素治疗的ICM患者作为MPP比较的参考。
- 图像质量由2名独立观察者按5分制(5=优秀,1=不可诊断)评估,分歧时联合阅片达成共识。
主要发现
- 18F-FDG图像质量评分为优秀42%、很好36%、良好17%、一般3%、不可诊断2%。
- 糖尿病患者与非糖尿病患者相比,优秀分别为29% vs 76%,很好41% vs 18%,良好24% vs 6%,一般4% vs 0%,不可诊断2% vs 0%。
- 平均质量评分为4.12±0.95,非糖尿病患者总体优于糖尿病患者(4.71±0.59 vs 3.88±0.96;P<0.0001)。
- 静脉葡萄糖负荷的平均MPP显著短于口服葡萄糖负荷(51±15 min vs 132±29 min;P<0.0001),同时胰岛素剂量更高(6.3±2.2 U vs 2.0±1.69 U;P<0.001)。
临床怎么用
- 对于ICM患者,可采用静脉葡萄糖负荷和胰岛素注射方案行18F-FDG PET心肌存活评估,以缩短准备时间。
- 糖尿病患者图像质量可能低于非糖尿病患者,解读时需注意。
局限性
- 研究未报告诊断准确性或临床结局数据,仅评估图像质量和准备时间。
- 样本量有限(59例),且为单中心研究,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We assessed image quality using a practical and time-efficient protocol for intravenous glucose loading and insulin injection before administration of 18F-FDG for PET myocardial viability evaluation in patients with ischemic cardiomyopathy (ICM), with and without type 2 diabetes mellitus. Methods: The metabolic preparation period (MPP) or optimal cardiac 18F-FDG uptake was determined from the time of intravenous infusion of 12.5 or 25 g of 50% dextrose to the time of 18F-FDG injection. Cardiac 18F-FDG image quality was evaluated according to a 5-point scoring system (from 5, excellent, to 1, nondiagnostic) by 2 independent observers. In cases of disagreement, consensus was achieved in a joint reading. Fifteen patients with ICM who underwent oral glucose loading and intravenous insulin administration served as a reference for MPP comparisons. Results: Fifty-nine consecutive patients (age, 63 ± 10 y; 48 men and 11 women) underwent rest 99mTc-tetrofosmin SPECT/CT and 18F-FDG PET/CT for the evaluation of myocardial viability. 18F-FDG image quality was scored as excellent in 42%, very good in 36%, good in 17%, fair in 3%, and nondiagnostic in 2%. When diabetic and nondiabetic patients were compared, the quality scores were excellent in 29% versus 76%, very good in 41% versus 18%, good in 24% versus 6%, fair in 4% versus 0%, and nondiagnostic in 2% versus 0%. The mean (±SD) quality score was 4.12 ± 0.95, and overall it was better in nondiabetic than in diabetic patients (4.71 ± 0.59 vs. 3.88 ± 0.96; P < 0.0001). Notably, the average MPP was significantly less with intravenous glucose loading than with oral glucose loading (51 ± 15 min vs. 132 ± 29 min; P < 0.0001), paralleled by higher insulin doses (6.3 ± 2.2 U vs. 2.0 ± 1.69 U; P < 0.001). Conclusion: Using a practical and time-efficient protocol for intravenous glucose loading and insulin administration before 18F-FDG injection reduces the MPP by 61% as compared with an oral glucose challenge and affords good-to-excellent image quality in 95% of ICM patients.
引用
- Mhlanga J, Derenoncourt P, Haq A, et al. 18F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol. J Nucl Med. 2021. PMID: 34503961. doi:10.2967/jnumed.121.262432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。